Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.95 USD | -1.35% | +1.70% | +18.46% |
May. 13 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.46% | 11.48M | |
+44.44% | 54.04B | |
+43.57% | 41.96B | |
-1.19% | 41.92B | |
-7.59% | 28.35B | |
+12.32% | 26.35B | |
-21.68% | 19B | |
+7.26% | 13B | |
+29.34% | 12.28B | |
+25.21% | 12.19B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Avalo Says Trial of AVTX-002 to Treat Non-Eosinophilic Asthma Did Not Meet Primary Endpoint; Shares Slump